Hamed S.M.; Aboshanab K.M.A.; El-Mahallawy H.A.; Helmy M.M.; Ashour M.S.; Elkhatib W.F.
(Mary Ann Liebert Inc., 2018)
Fluoroquinolones (FQs) are the drugs of choice for prophylaxis of bacterial infections in immunocompromised cancer patients. This study aimed to investigate FQ resistance and the prevalence of plasmid-mediated quinolone ...